Frontier Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Frontier Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-15,151	Closed	-$817K	–	331
2016 Q3	$817K	Sell	15,151 -2,251	-13%	-$145K	0.01%	298
2016 Q2	$1.28M	Sell	17,402 -1,669	-9%	-$118K	0.01%	288
2016 Q1	$1.22M	Sell	19,071 -2,523	-12%	-$159K	0.01%	297
2015 Q4	$1.49M	Buy	+21,594	New	+$1.43M	0.01%	305

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Frontier Capital Management's BMY Position: Q4 2016 in Review

Frontier Capital Management sold out of Bristol-Myers Squibb (BMY) in Q4 2016, closing a stake of 15,151 shares — an estimated $817K sold.

Frontier Capital Management first reported a position in BMY in Q4 2015 and held it in 4 quarters. The position peaked at $1.49M in Q4 2015. 1,601 funds tracked by Wall St. Rank hold BMY as of Q4 2016.

Frontier Capital Management reported no remaining Bristol-Myers Squibb position as of Q4 2016 after selling out during the quarter.
Frontier Capital Management sold 15,151 Bristol-Myers Squibb shares in Q4 2016, an estimated $817K.
Frontier Capital Management first reported a position in Bristol-Myers Squibb in Q4 2015 and held it in 4 quarters.
Frontier Capital Management's Bristol-Myers Squibb position peaked at $1.49M in Q4 2015.
1,601 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2016.

Based on Frontier Capital Management's 13F filing for Q4 2016, filed 3 Feb 2017.